STOCK TITAN

SANUWAVE Health to Host Conference Call and Provide Business Update

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

SUWANEE, GA, Oct. 20, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (SNWV), a leading provider of next-generation wound care products, announced it will hold a conference call on Friday, October 22, 2021, at 9:00 am ET to discuss its recent business activity, provide an update on SEC filings and detail strategic initiatives.

Telephone access to the live call will be available by dialing the following numbers:

Toll Free: 1-877-407-0784

International: 1-201-689-8560

A replay of the call can be accessed through November 5, 2021, at:

Toll Free: 1-844-512-2921

International: 1-412-317-6671

Replay Passcode: 13724589

About SANUWAVE Health

SANUWAVE Health (SNWV) is focused on the research, development, and commercialization of its patented, Energy First non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. 

SANUWAVE’s end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body’s normal healing processes. SANUWAVE applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, plastic/cosmetic, and cardiac/endovascular conditions. For more information, please visit www.SANUWAVE.com.

Investor Relations Contact
SANUWAVE Health, Inc.
Kevin Richardson II
Chairman and Chief Executive Officer
978-922-2447
investorrelations@SANUWAVE.com


SANUWAVE HEALTH INC

OTC:SNWV

SNWV Rankings

SNWV Latest News

SNWV Stock Data

22.24M
622.26M
10.73%
10.11%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
Eden Prairie

About SNWV

sanuwave, inc. is an emerging leader in the development and commercialization of noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures. sanuwave's portfolio of products and product candidates activate biologic signaling and angiogenic reponses, including revascularization and microcirculation, helping to restore the body's normal healing processes and regeneration. these devices, based on pulsed acoustic cellular expression (pace™) technology, are being developed and commercialized for use in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions.